Suppr超能文献

负载DNA-Hsp65/TDM的聚乳酸-羟基乙酸共聚物微球的组织分布及被吞噬细胞摄取的情况。

Tissue distribution of DNA-Hsp65/TDM-loaded PLGA microspheres and uptake by phagocytic cells.

作者信息

Trombone Ana Paula F, Silva Celio L, Almeida Luciana P, Rosada Rogerio S, Lima Karla M, Oliver Constance, Jamur Maria C, Coelho-Castelo Arlete A M

机构信息

Departamento de Bioquímica e Imunologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Av, Bandeirantes, 3900, 14049-900, Ribeirão Preto, SP, Brasil.

出版信息

Genet Vaccines Ther. 2007 Sep 20;5:9. doi: 10.1186/1479-0556-5-9.

Abstract

This study aimed to demonstrate that microspheres, used as delivery vehicle of DNA-Hsp65/TDM [plasmid DNA encoding heat shock protein 65 (Hsp65) coencapsulated with trehalose dimycolate (TDM) into PLGA microspheres], are widely spread among several organs after intramuscular administration in BALB/c mice. In general, we showed that these particles were phagocytosed by antigen presenting cells, such as macrophages and dendritic cells. Besides, it was demonstrated herein that draining lymph node cells presented a significant increase in the number of cells expressing costimulatory molecules (CD80 and CD86) and MHC class II, and also that the administration of the DNA-Hsp65/TDM and vector/TDM formulations resulted in the up-regulation of CD80, CD86 and MHC class II expression when compared to control formulations (vector/TDM and empty). Regarding the intracellular trafficking we observed that following phagocytosis, the microspheres were not found in the late endosomes and/or lysosomes, until 15 days after internalization, and we suggest that these constructions were hydrolysed in early compartments. Overall, these data expand our knowledge on PLGA [poly (lactic-co-glycolic acid)] microspheres as gene carriers in vaccination strategies, as well as open perspectives for their potential use in clinical practice.

摘要

本研究旨在证明,作为DNA-Hsp65/TDM(编码热休克蛋白65的质粒DNA与海藻糖二霉菌酸酯共包封于聚乳酸-羟基乙酸共聚物微球中)递送载体的微球,在BALB/c小鼠肌肉注射后广泛分布于多个器官。总体而言,我们发现这些颗粒被抗原呈递细胞吞噬,如巨噬细胞和树突状细胞。此外,本文还证明引流淋巴结细胞中表达共刺激分子(CD80和CD86)和MHC II类分子的细胞数量显著增加,并且与对照制剂(载体/TDM和空载体)相比,DNA-Hsp65/TDM和载体/TDM制剂的给药导致CD80、CD86和MHC II类分子表达上调。关于细胞内运输,我们观察到吞噬后,直到内化后15天,微球都未出现在晚期内体和/或溶酶体中,我们推测这些结构在早期区室中被水解。总体而言,这些数据扩展了我们对聚乳酸-羟基乙酸共聚物微球作为疫苗接种策略中基因载体的认识,并为其在临床实践中的潜在应用开辟了前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c1a/2042973/1b35ea4dbcd5/1479-0556-5-9-1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验